ADIPOQ and type 2 diabetes mellitus: The current study was conducted to evaluate the modulatory impact on adiponectin of both CANA and INDA, as well as their subsequent impact on insulin resistance, overall glycemic control, changes in adipose tissue associated with T2DM, and glucose use in the skeletal muscles.